An LC–MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma is a research paper published in Bioanalysis (2024). On theSindex it has a DataRank of 0.104. It has been cited 1 time, with 1 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
From 0 citing papers with measurable signal
This paper's DataRank is currently driven only by its base citation score. None of the citing papers had measurable citation signal.
Learn more about DataRank methodology →National Cancer Institute of the National Institutes of Health
Grant: U24CA247643, UM1CA186690 and P30CA033572
NCI NIH HHS
Grant: R50 CA211241
NIH HHS
Grant: P30CA033572, U24CA247643, UM1CA186690
NCI NIH HHS
Grant: P30 CA033572
NCI NIH HHS
Grant: P30 CA047904
NCI NIH HHS
Grant: U24 CA247643
NCI NIH HHS
Grant: UM1 CA186690
FWCI
0.16
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals